TABLE 2.
Name | Sequence (5′ to 3′)a |
---|---|
G9-A | TAAGAAAATGAAAAATTTAAT |
G9-C | AATTCTTGAAATTTCTTTCTA |
G10-A | TGGTAATATTAGTACTTTATG |
G10-C | TTTTTTTCTTTTATCTATTTT |
G11-A | TTAAATCTTTGAAATATTGCA |
G11-C | GAATTTCTTTTTCTTTCTCTT |
G12-A | AAAATGTAACAGCTGAATGTA |
G12-C | TGACCACCATCTTTTGCTTGC |
G13-A | TGGCGAGTTGGTTAAAATTAC |
G13-C | GGGTGTGTTATCGTGGGAACT |
G14-A | TTGTAATGAGTAGAGCATTTG |
G14-C | GTGGTGGATTAAACAGACTGT |
G15-A | CTTGAAAATTTAATTTGTATG |
G15-C | CCTTGCATTAACTCTTTATCT |
G16-A | AAAGATAGTATACTTTGTGTA |
G16-C | TTTTTCTTTTACATTTTGTTT |
G17-A | ACAGAAGTAGTGATTTTTGAG |
G17-C | TCGCATCAATCTTGCAAGAAA |
G18-A | CATGCAAAATCTGGGCTGTAG |
G18-C | ACTGCACAAATAATTAAATTT |
Bio-E43 | biotin-AAAATTTTAGTCAAATTTGGAGTG |
Bio-104 | biotin-TGTTAAAATGTAACAGCTGAATGTAACAAA |
R-8 | GCAATATTTCAAAGATTTAAA |
E-8 | CATAAGTTACTCC |
E-43 | AAAATTTTAGTCAAATTTGGAGTG |
104-F | TGTTAAAATGTAACAGCTGAATGTAACAAA |
104-R | TTTGTTACATTCAGCTGTTACATTTTAACA |
104N-F | ATGTAACAGCTGAATGTA |
104N-R | TACATTCAGCTGTTACAT |
164-F | TGAGTAGAGCATTTGCAATGGAGAGATTTT |
164-R | AAAATCTCTCCATTGCAAATGCTCTACTCA |
164N-F | GAGCATTTGCAATGGAGA |
164N-R | TCTCCATTGCAAATGCTC |
BSV-G | AAAAAACTCGAGTGGCCGAGGAGCAGGACTGACACG |
BSV-H | AAAAAACTCGAGTCTGATTAGAAAAACTCATCGAG |
GFP-1 | ATAATAGGATCCATACATATGAGTAAAGGAGAAG |
GFP-2 | ATAATAAAGCTTATTATTTGTATAGTTCATCCATGCCATG |
G-1 | AAAAAAGGTACCATATATAGCAAAG |
G-2 | TTTTTTGGATCCTCCATAAAGTACTAATATTAC |
G-2A | TTTTTTGGATCCTCCATAAAGTACTAAT |
G-3 | AAAAAAGGTACCGTTTTGTTAAAATGTAACAGCTG |
A-1 | AAAAAAGGTACCCCTCTCCTTGAAGGTG |
A-2 | TTTTTTGGATCCTCCATAAGTCCTAATCATAC |
A-4 | ATAATGGATCCTCCATAAGTCCTAATATTACCAC |
A-10 | ATAATAGGTACCTTGCATTTATTATGTATTGTGG |
E-116 | ATATAATTTTGTTACATTCAG |
BBK-2 | CATAATGGATCCTCCATAAGCCTTAAGCTTAC |
21-1 | ATAATAGGTACCACAAGCTCCTTATAAGTG |
21-2 | TTTTTTGGATCCTCCATAAATCTTAATCATAC |
PRO-1 | CGCGCTTATGGAG |
PRO-2 | GATCCTCCATAAGCGCGGTAC |
Sequences of specific restriction endonuclease recognition sites are underlined.